Geode Capital Management, LLC Cassava Sciences Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,008,593 shares of SAVA stock, worth $2.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,008,593

Previous 967,304 4.27%

Holding current value

$2.85 Million

Previous $11.9 Million 148.47%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$9.57 - $35.08 $395,135 - $1.45 Million	41,289 Added 4.27%	1,008,593 $29.7 Million
Q2 2024 Aug 09, 2024	BUY	$12.35 - $26.11 $808,480 - $1.71 Million	65,464 Added 7.26%	967,304 $11.9 Million
Q1 2024 May 13, 2024	BUY	$18.44 - $26.41 $513,443 - $735,360	27,844 Added 3.19%	901,840 $18.3 Million
Q4 2023 Feb 13, 2024	BUY	$12.64 - $30.11 $552,949 - $1.32 Million	43,746 Added 5.27%	873,996 $19.7 Million
Q3 2023 Nov 13, 2023	BUY	$16.64 - $25.32 $448,348 - $682,222	26,944 Added 3.35%	830,250 $13.8 Million
Q2 2023 Aug 11, 2023	BUY	$21.59 - $27.88 $957,516 - $1.24 Million	44,350 Added 5.84%	803,306 $19.7 Million
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $1.18 Million - $1.83 Million	50,164 Added 7.08%	758,956 $18.3 Million
Q4 2022 Feb 13, 2023	BUY	$27.82 - $44.16 $666,038 - $1.06 Million	23,941 Added 3.5%	708,792 $20.9 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $184,675 - $577,437	11,309 Added 1.68%	684,851 $28.6 Million
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $476,907 - $1.07 Million	27,695 Added 4.29%	673,542 $18.9 Million
Q1 2022 May 13, 2022	BUY	$32.6 - $53.05 $307,189 - $499,890	9,423 Added 1.48%	645,847 $24 Million
Q4 2021 Feb 11, 2022	SELL	$36.77 - $90.91 $75,341 - $186,274	-2,049 Reduced 0.32%	636,424 $27.8 Million
Q3 2021 Nov 12, 2021	BUY	$41.79 - $135.3 $262,942 - $851,307	6,292 Added 1.0%	638,473 $39.6 Million
Q2 2021 Aug 13, 2021	BUY	$32.15 - $89.72 $2.27 Million - $6.33 Million	70,504 Added 12.55%	632,181 $54 Million
Q1 2021 May 12, 2021	BUY	$7.09 - $87.95 $736,346 - $9.13 Million	103,857 Added 22.69%	561,677 $25.2 Million
Q4 2020 Feb 12, 2021	BUY	$6.79 - $12.25 $1.03 Million - $1.86 Million	152,233 Added 49.82%	457,820 $3.12 Million
Q3 2020 Nov 13, 2020	BUY	$2.86 - $11.51 $128,722 - $518,042	45,008 Added 17.27%	305,587 $3.52 Million
Q2 2020 Aug 13, 2020	BUY	$2.04 - $9.64 $304,127 - $1.44 Million	149,082 Added 133.71%	260,579 $802,000
Q1 2020 May 14, 2020	SELL	$3.26 - $9.65 $106,778 - $316,076	-32,754 Reduced 22.71%	111,497 $458,000
Q4 2019 Feb 13, 2020	BUY	$1.1 - $6.12 $76,470 - $425,456	69,519 Added 93.02%	144,251 $750,000
Q2 2019 Aug 14, 2019	BUY	$1.02 - $1.34 $8,837 - $11,609	8,664 Added 13.11%	74,732 $90,000
Q1 2019 May 14, 2019	BUY	$0.92 - $1.29 $60,782 - $85,227	66,068 New	66,068 $85,000

Others Institutions Holding SAVA

# of Institutions

205

Shares Held

13.9M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $113M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cassava Sciences Inc Transaction History